Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
ID: ARPA-H-SOL-24-104Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)

Original Source

https://sam.gov/opp/9a301dc812ba47268323e3130e381f19/view
Timeline
  1. 1
    Posted Mar 14, 2024, 8:58 PM UTC
  2. 2
    Updated Sep 25, 2024, 12:00 AM UTC
  3. 3
    Due Mar 4, 2029, 4:59 AM UTC
Description

The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.

Point(s) of Contact
SEE DESCRIPTION SECTION
do_NOT_use_THIS_email_ADDRESS@arpa-h.gov
Files
Title
Posted
A07_HSF_ISO_Amend_1.pdf
Sep 25, 2024, 10:37 PM UTC
The Advanced Research Projects Agency for Health (ARPA-H) has announced the Innovative Solutions Opening (ISO) under solicitation number ARPA-H-SOL-24-104, inviting proposals for groundbreaking healthcare technologies. This solicitation aims to support innovative, disease-agnostic research projects that can significantly enhance health outcomes. Key interest areas include breakthrough technologies for maternal and fetal health, genetic and cellular therapies, and novel diagnostic tools. Eligible participants include universities, non-profits, and small businesses, with a deadline for submission set until March 3, 2029. Proposers must initially submit a solution summary for feedback before proceeding with full proposals, which will be evaluated based on scientific merit, relevance to ARPA-H’s mission, and proposer capabilities. The solicitation emphasizes transformative, high-impact solutions over incremental research and excludes proposals for traditional policy changes or infrastructure projects. Awards will primarily include Other Transactions and Cooperative Agreements, allowing for flexibility in negotiation without the constraints of Federal Acquisition Regulation. The process encourages innovative approaches that incorporate open standards and interoperability in healthcare technology.
Appendix A - Solutions Summary Template.docx
Sep 25, 2024, 10:37 PM UTC
The ARPA-H solicitation document outlines the requirements for submitting solution summaries in response to government Requests for Proposals (RFPs). It emphasizes the need for clarity and innovation in proposed technology concepts that address high-priority interest areas. Key sections include a Concept Summary where submitters detail their solutions and the problems they address, and Innovation and Impact, where the potential disruptiveness and superiority of the proposal over existing technologies should be demonstrated with measurable metrics. Additionally, the document specifies the Proposed Work section, where deliverables, milestones, and technical approaches must be clearly outlined alongside an analysis of technical challenges and risks. Team Organization and Capabilities highlight the roles of project members, supported by a Basis of Estimate (BOE) detailing financial requirements, work breakdown, and project costs. Submissions are restricted to six pages and must be formatted according to specified guidelines, ensuring readability and organization. This document serves to enhance the clarity and effectiveness of proposals within the context of federal funding opportunities, focusing on innovative solutions in healthcare and related fields.
Attachments - Bundle of Attachments.zip
Mar 28, 2024, 7:16 AM UTC
Bundle_of_Attachments-Amend_1.zip
Sep 25, 2024, 10:37 PM UTC
HSF Open Office Innovative Solutions Opening.pdf
Mar 28, 2024, 7:16 AM UTC
The ARPA-H Health Science Futures Office has released an Innovative Solutions Opening (ISO) solicitation aimed at advancing revolutionary healthcare technologies through proposals that tackle significant health challenges. Eligible applicants, including universities and small businesses, are encouraged to submit solution summaries by March 3, 2025, before full proposals can be considered, and multiple awards are anticipated with a focus on innovative, disruptive solutions in biomedical research. The initiative emphasizes novel technologies that can address a wide range of diseases and improve health outcomes, while excluding projects that represent merely incremental advances.
Lifecycle
Title
Type
Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
Currently viewing
Solicitation
Office-Wide Innovative Solutions Opening
Presolicitation
Similar Opportunities
Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.
PROactive Solutions for Prolonging Resilience (PROSPR)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the PROactive Solutions for Prolonging Resilience (PROSPR) program, aimed at extending the healthspan of Americans by 20 years. This initiative invites eligible applicants to develop innovative interventions focused on early disease prevention and addressing age-related health decline, which significantly impacts healthcare costs. The program encompasses three Technical Areas: developing a precise intrinsic capacity score for health predictions, repurposing FDA-approved drugs to enhance healthspan, and testing second-generation healthspan interventions through clinical trials. Interested parties can find more information and submit inquiries to the PROSPR Team at PROSPR@arpa-h.gov, with proposals due by the specified deadlines outlined in the solicitation documents.
Research and Development of the FDA ARGOS System
Buyer not available
The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified vendors for the research and development of the FDA ARGOS System, as outlined in a Sources Sought Notice. The primary objective is to enhance the FDA ARGOS database and develop bioinformatics and artificial intelligence tools to analyze genetic data, thereby improving public health preparedness and regulatory processes related to medical countermeasures against infectious diseases. This initiative is crucial for advancing diagnostic capabilities through Next Generation Sequencing (NGS) technology, which can identify microbial pathogens efficiently and accurately. Interested parties must submit their responses, including a Vendor Feedback Form, to Nicholas Bisher and Kimberly Pennix by May 2, 2025, at 2:00 PM EST, as no solicitation is currently available.
RRPV Solicitation Summary: Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is seeking proposals for the establishment of a Central Influenza and Emerging Infectious Diseases Vaccine Immunoassay Laboratory. This initiative aims to enhance national health security by facilitating the rapid development of vaccines in response to potential pandemics, with a focus on conducting immunoassays to support vaccine research and clinical trials. The successful offeror will play a critical role in strengthening biodefense infrastructure by providing standardized laboratory services, with proposals due by May 30, 2025, and questions accepted until April 24, 2025. Interested parties can contact Rebecca Harmon at rebecca.harmon@ati.org for further information.
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 for advanced research and development of Medical Countermeasures (MCMs) aimed at addressing public health threats such as chemical, biological, radiological, and nuclear (CBRN) incidents, as well as emerging infectious diseases and pandemic influenza. The initiative seeks to foster public-private partnerships to enhance the development and responsiveness of life-saving MCMs, emphasizing the importance of technological maturity, regulatory compliance, and manufacturing standards in the evaluation process. This opportunity is critical for strengthening national health security and improving preparedness for future public health emergencies, with an open submission period running until September 25, 2028, at 4:30 PM Eastern Time. Interested parties can direct inquiries to BARDA-BAA@hhs.gov for further information.
BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Easy Broad Agency Announcement (EZ-BAA) BAA-22-100-SOL-00003, which focuses on innovative research to enhance public health preparedness against various biomedical threats. The initiative encompasses multiple Areas of Interest (AOIs), including the development of medical countermeasures for emerging infectious diseases, repurposing existing drugs for chemical threats, and advancing technologies for at-home diagnostics. Interested parties must have active registration with SAM.gov and are encouraged to engage in pre-submission consultations; abstract submissions are due by specified deadlines, with funding amounts contingent on the quality of proposals and alignment with program goals. For further inquiries, interested vendors can contact the BARDA DCMA DRIVe Team at DRIVeAcquisitions@hhs.gov.
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
Buyer not available
Special Notice DEPT OF DEFENSE is seeking proposals for extramural biomedical research and development. This opportunity is issued by the DEFENSE HEALTH AGENCY (DHA) under the BROAD AGENCY ANNOUNCEMENT (BAA) HT9425-23-S-SOC1. The purpose of this BAA is to solicit research and development ideas to advance the state-of-the-art or increase knowledge in the field. The projects funded under this BAA should focus on basic and applied research rather than the development of specific systems or hardware solutions. The research and development funding is expected to benefit both military and civilian medical practice and knowledge. Interested parties must submit a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP). If selected, the offeror will be invited to submit a full proposal or application through Grants.gov. The BAA is open for a 5-year period, from August 1, 2023, to July 31, 2028. The BAA with revised research areas of interest and General Submission Instructions can be found on Grants.gov using opportunity number HT9425-23-S-SOC1.
BARDA DRIVe EZ-BAA-22-100-SOL-00003
Buyer not available
Solicitation: HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking proposals for BARDA DRIVe EZ-BAA-22-100-SOL-00003. This procurement is for health research and development services, health care services, and experimental development. The announcement serves as a reissuance of the BARDA DRIVe EZ-BAA and supersedes prior iterations. For more information, please visit https://drive.hhs.gov/.